vitro. I think this manuscript is of great interest to the readership of the EMBO Journal.
Comments:
The use of many acronyms makes the paper difficult to read. I understand the need for constraining space, but at the same time I favor clarity over brevity. This is particularly important in the figures, where annotation of FACS plots would be a lot clearer if instead of BV, Blimp1-Venus is used. Same for all the other reporter genes. In figure 1A , Forskolin, Rolipram and Scf are better written out
The authors provide a schematic of the culture conditions used to screen for factors that induce female germ cell formation in figure 1A . I think at the end of the manuscript, a similar figure should be included, clearly outlining the timing and conditions that robustly induce female germ cell formation. As is, this is not entirely clear. For example, are Rolipram and Forskolin continually included in the culture when female germ cell differentiation is induced with RA and BMP2?
Referee #2:
The group of Mitinori Saitou have been at the forefront of work to produce gametes from pluripotent stem cells in vitro. Previous work has described production of primordial germ cells that could be differentiated by exposure to undefined gonadal cues to mature germ cells. The work presented in Miyauchi et al. represents a further step in defining an in vitro process to produce more differentiated germ cells. The study identifies a heretofore unknown role for the growth factor Bmp2, in combination retinoic acid, to induce specification of female germ cell identity. The quality of the data is high and the conceptual insights important enough to warrant publication in EMBO J.
Points:
• Both Dazl and Ddx4 are expressed in both male and female germ cells prior to the onset of sexual differentiation (and prior to germ cell exposure to retinoic acid). Data in this paper argue that further induction of these genes occurs later in differentiation in response to retinoic acid. This biphasic expression pattern should be discussed within the Discussion section.
• The interconnection of cultured germ cells into cyst-like structures could be further elucidated by immuno-staining the culture cells with an antibody against Tex14, which marks inter-cytoplasmic bridges connecting cysts of germ cells in fetal ovary (Greenbaum et al. 2009 ).
• In Figure 2 the authors show very nice staining for meiotic chromosomes in cultured germ cells. They observe the expected global down-regulation of gH2AX signal in pachytene as double strand breaks are repaired. Given that the cells used to induce germ cells fate are XY in origin, did the authors observe any examples of retained gH2AX on the un-synapsed sex chromosomes in these cells?
• The RNA-Seq analysis of SK1 cells should be compared to published data (Soh et al. 2015) on Stra8-deficient embryonic ovaries. How many of the Stra8 dependent genes observed to be misexpressed in SK1 cells also fail to be induced in Stra8 knockouts?
• The author propose a very interesting model for the development of germ cells, integrating extracellular signaling and DNA methylation. This model posits a developmental window (between E11.5-E13.5), when germ cells have lost their DNA methylation, but still do not express Stra8 or markers of female differentiation. A role for chromatin in this process seems likely, given the results of Yokobayashi et al. 2013 . In this study Polycomb Repressive Complex 1 (PRC1) was found to be necessary to prevent precocious retinoic acid-dependent activation of Stra8 in fetal female germ cells. This work and the broader role of chromatin (which is covered in greater detail in the Ohta et al. manuscript, currently under consideration) in primordial germ cell like cells during the phase of DNA demethylation needs to be discussed in relation to the new findings reported in the current manuscript (assuming that the Ohta et al. manuscript would be published prior to or concurrently with this study). Microarray data from Yokobayashi et al. 2013 examining PRC1-dependent changes in gene expression in fetal ovarian germ cells should also be compared to the RNA-Seq generated here to identify overlapping requirement sets of genes. Response 2. In response to the Referee's comment, we spelled out the acronyms for the reporters, chemicals and cytokines described in the Figures. We also defined such acronyms more explicitly upon their first appearance in the main text, as well as in the legend to each Figure (p 5, "A system for analyzing the sex-determination mechanism of germ cells" section, the second paragraph, in the revised manuscript).
Comments
The authors provide a schematic of the culture conditions used to screen for factors that induce female germ cell formation in figure 1A . Response 3. In response to the Referee's comment, we provided a scheme of the culture condition used to induce the female germ-cell fate in PGCLCs in Fig. 7A in the revised manuscript. We included Forskolin and Rolipram during the entire culture period and we clarified this point in the revised manuscript and in Fig. 1A (its legend) and 7A (p 5, "A system for analyzing the sexdetermination mechanism of germ cells" section, the third paragraph, in the revised manuscript).
Referee #2:
The Response 2. According to the Referee's comment, we have added a discussion on the expression dynamics of late germ-cell genes, including Dazl and Ddx4, and fetal oocyte genes in response to RA and BMP in the DISCUSSION section of the revised manuscript (p 13, "DISCUSSION" section, the third paragraph, in the revised manuscript).
Response 3. In response to the Referee's comment, we immuno-stained the cultured PGCLCs with RA and BMP2 at culture day 9 (c9) and an embryonic ovary at E15.5 by an anti-TEX14 antibody. As shown in Fig. 1F in the revised manuscript, the cells within the cyst-like structures exhibited TEX14-positive inter-cytoplasmic bridge-like structures highly similar to those among fetal oocytes, providing further evidence that the combined action of RA and BMP signaling leads cultured PGCLCs into the female pathway. We provided the relevant data and statements in the revised manuscript (Fig. 1F , p 5, "A system for analyzing the sex-determination mechanism of germ cells" section, the fifth paragraph, in the revised manuscript).
• In Figure 2 the authors show very nice staining for meiotic chromosomes in cultured germ cells. They observe the expected global down-regulation of gH2AX signal in pachytene as double strand breaks are repaired. Given that the cells used to induce germ cells fate are XY in origin, did the authors observe any examples of retained gH2AX on the un-synapsed sex chromosomes in these cells?
Response 4. In response to the Referee's comment, we performed a spread analysis for male PGCLCs cultured with RA and BMP2 at c9, and as shown in Appendix Fig. S2E in the revised manuscript, we identified cells at the pachytene stage that appeared to retain the gH2AX signal on the un-synapsed sex chromosomes. We provided the relevant data and statements in the revised manuscript (Appendix Fig. S2E , p 13, "DISCUSSION" section, the fifth paragraph, in the revised manuscript).
• The RNA-Seq analysis of SK1 cells should be compared to published data (Soh et al. 2015) on Stra8-deficient embryonic ovaries. How many of the Stra8 dependent genes observed to be misexpressed in SK1 cells also fail to be induced in Stra8 knockouts?
Response 5. In response to the Referee's comment, we examined the expression of genes misregulated in Stra8-deficient embryonic ovaries reported by Soh et al. (Soh, Junker et al., 2015) in SK1 cells. As shown in Fig. EV5E in the revised manuscript, all twelve genes reported to be dependent on Stra8 were down-regulated in c9 SK1 cells. We provided this data and a relevant statement in the revised manuscript (Fig. EV5E, p 10 , "Role of STRA8 in fetal primary oocyte development" section, the second paragraph, in the revised manuscript).
• The author propose a very interesting model for the development of germ cells, integrating extracellular signaling and DNA methylation. This model posits a developmental window (between E11.5-E13.5), when germ cells have lost their DNA methylation, but still do not express Stra8 or markers of female differentiation. A role for chromatin in this process seems likely, given the results of Yokobayashi et al. 2013. In this study Polycomb Repressive Complex 1 (PRC1) was found to be necessary to prevent precocious retinoic acid-dependent activation of Stra8 in fetal female germ cells. This work and the broader role of chromatin (which is covered in greater detail in the Ohta et al. manuscript, currently under consideration) in primordial germ cell like cells during the phase of DNA demethylation needs to be discussed in relation to the new findings reported in the current manuscript (assuming that the Ohta et al. manuscript would be published prior to or concurrently with this study). Microarray data from Yokobayashi et al. 2013 examining PRC1-dependent changes in gene expression in fetal ovarian germ cells should also be compared to the RNA-Seq generated here to identify overlapping requirement sets of genes.
Response 6. In response to the Referee's comment, we analyzed the 524 genes aberrantly upregulated in female germ cells deficient in Rnf2, a key component of PRC1, at E12.5 (Yokobayashi, Liang et al., 2013). In good agreement with the notion that PRC1 plays a key role in coordinating the timing of sexual differentiation of female germ cells, we found that while a majority of the 524 genes were those involved in basic cellular functions ("cell cycle", "protein dephosphorylation", etc.), as many as 97 genes (18.5%) were late germ-cell (Mael, Mov10l1, Tdrd7, Tex11, Tex14, etc.) or fetal oocyte genes (Stra8, Rec8, Sycp1, Sycp3, Smc1b, Hormad2, Sohlh2, etc.). We provided the relevant data and discussion in the revised manuscript (Appendix Fig. S2A, p 13, "DISCUSSION" section, the fourth paragraph, in the revised manuscript).
Referee #3:
In 
Overall, this is an interesting study which will allow more thorough investigation into the mechanisms of female sex-determination in PGCs. It also highlights the important role of BMP signalling in PGC specification, and reveals that BMP signalling at different stages of PGC specification is required for the activation of different sets of genes.
Response 1. We would sincerely like to thank the Referee for the encouraging comments on our manuscript.
General comments on the paper: The whole manuscript would benefit from some tightening up. Sometimes the point being made is not clear because of the language used. One of the most interesting points here is that BMP signalling is required in a different context in late PGC specification compared to early PGC specification. This point is a little bit lost in the text.
Response 2. In response to the Referee's comment, we tightened up the manuscript where possible and re-edited the entire manuscript with the assistance of a professional English editing service. We also emphasized the differential function of BMP signaling between PGC specification and female germ-cell induction in the ABSTRACT of the revised manuscript. We sincerely hope that the revision will meet with the Referee's approval. Fig 1A. Response 3. The manuscript by Ohta et al., 2017 has now been published in the EMBO Journal (Ohta, Kurimoto et al., 2017), and we cited this work in the relevant passages of the revised manuscript. Moreover, according to the Referee's comment, we elaborated the scheme for the expansion culture in Fig. 1A Response 4. We would like to thank the Referee for this comment. In response to the Referee's suggestion, first, by Western blot analyses, we measured the level of phosphorylated (p) SMAD1/5/8 in d4c3 PGCLCs in response to the stimulation that induces the female germ cell fate, i.e., BMP2 and RA. As shown in Fig. EV3A in the revised manuscript, the stimulation by BMP2 and RA specifically elevated the pSMAD1/5/8 level, which was in turn blocked by the administration of LDN193189, which selectively inhibits the BMP signaling through the ALK2/3 receptors.
The manuscript refers to one paper (Ohta et al, 2017) in several places, and yet this manuscript is still in revision and not yet published. In light of this, the authors could add further detail to their explanation of the expansion culture conditions in
Second (Fig. EV3B in the revised manuscript) .
Third, we re-analyzed the RNA-seq data during the female germ cell specification in vivo and in vitro for the expression levels of key components of the BMP signaling pathway (Fig. EV4A ). This analysis revealed the following. 1) Consistent with the UHC and PCA analyses (Fig. 4A, B) , the expression profiles/dynamics of the components of the BMP signaling pathway are highly similar during the female germ cell specification in vivo and in vitro. 2) In vitro, genes such as Id1 and Id2 showed acute up-regulation in response to BMP2 and RA, but not RA alone, and critically, in vivo, they were sharply up-regulated between E11.5 and E12.5 in female, but not male, germ cells (Fig.  EV4A in the revised manuscript) . Collectively, these findings demonstrate that the BMP signaling is indeed active during the female germ cell specification in vivo and in vitro. We provided these data and relevant statements in the revised manuscript (Fig. EV3A, B , 4A, p 7, "BMP and RA commit PGCLCs to the female fate" section, the first paragraph, in the revised manuscript).
The authors base their study around the use of two reporter ESC lines which they generated (to report blimp1/stella and ddx4/dazl respectively). One important control would be for the authors to introduce these ESCs into chimeras and transfer them back to the mother. They could recover the embryos at PGC stages (E9.5/ E11.5/ E13.5) and check that the ESCs contribute to the embryo and to PGCs and also report the PGC lineage faithfully.
Response 5. The fact that the Blimp1-mVenus (BV) and Stella-ECFP (SC) transgenes recapitulate the expression of Blimp1 and Stella, respectively, has already been described in our previous publications (Ohinata, Sano et al., 2008). The faithful expression of the Ddx4/mVH-RFP (VR) transgenes has also been reported previously (Imamura, Aoi et al., 2010). As shown in Fig. EV1C in the original manuscript (Fig. EV1C, D) , we have verified that the Dazl-tdTomato (DT) and Ddx4/mVH-RFP (VR) transgenes recapitulate the expression of Dazl and Ddx4, respectively, in that they initiate weak expression at around E11.5 and show robust expression after E12.5 both in the testes and ovaries. Note that the Dazl-tdTomato transgenic mouse lines have been established from the BVSCDT ESCs.
To further verify the specific expression of DT and VR at a cellular level, we immuno-stained the sections of the embryonic gonads of DT and VR mice at E12.5/E13.5, which revealed specific expression of DT and VR in DDX4-positive germ cells (Fig. EV1E in the revised manuscript) . Please also note that d4c7 PGCLCs, which bear a transcriptome similar to that of migrating PGCs (Fig. 4A, B) (Ohta et al., 2017), express BVSC robustly, but not DR or VR (Fig. EV1F , G in the revised manuscript).
These findings/data, together with the fact that the cells sorted based on reporter expression recapitulate the transcriptome dynamics of the female germ-cell specification pathway as appreciated by the Referee "The transcriptional analysis in particular is very good evidence that their system is working as they say", demonstrate that the BVSCDT/VR reporters recapitulate the expression of their endogenous genes. We provided these data and relevant statements in the revised manuscript (Fig. EV1, p 5 , "A system for analyzing the sex-determination mechanism of germ cells" section, the second paragraph, in the revised manuscript).
It is not always clear in the manuscript why one ESC reporter cell line is used over the other for different experiments. Perhaps this could be clarified.
Response 6. We used BVSCDT cells for the first screening and used BVSCVR cells for the verification of the results. We subsequently used BVSCVR cells to evaluate the signaling requirements for the female germ-cell fate in a detailed fashion, since VR exhibits a more specific response to RA and BMPs. We used BVSC cells for the experiments involving IF analyses to secure one fluorescence channel. We explained these approaches in the revised manuscript (p 5, "A system for analyzing the sex-determination mechanism of germ cells" section, the third, fourth, fifth paragraphs, p 7, "BMP and RA commit PGCLCs to the female fate" section, the first paragraph, in the revised manuscript). Response 9. We would like to thank the Referee for this comment. To address this, we performed a cell-cycle analysis of the PGCLCs cultured under the control condition, those cultured with RA, and those cultured with BMP2 and RA at culture day (c) 5, 7, and 9. As shown in Fig. 2F in the revised manuscript, consistent with our original data as well as with those shown for wild-type and Stra8 KO cells (Fig. 5C ), a majority of the cells (~58.7%) at c9 cultured with BMP2 and RA were found to be in the G2/M phase (4C state), whereas less than 20% of the cells cultured under the control condition or with RA alone were in the G2/M phase. We provided these data and relevant statements in the revised manuscript (Fig. 2F, p 7 , "BMP and RA commit PGCLCs to the female fate" section, the third paragraph, in the revised manuscript).
Figure 3A-C: The authors observe that BMP2 alone can induce female germ cell fate and conclude that this is because there is RA in the serum and KSR in the culture media. But isn't there also BMP in serum? If so, why doesn't RA alone work?
Response 10. We would like to thank the Referee for this comment. We added a passage explaining that the concentration of BMP present in the serum may have been too low (negligible) to induce the female fate (p 7, "BMP and RA commit PGCLCs to the female fate" section, the fourth paragraph, in the revised manuscript).
Figure 3E & H: Ddx4 is still there in BMP inhibited conditions?
Response 11. This might be because we provided the BMP inhibitor from E11.5 onwards, at which time the up-regulation of Ddx4 had already begun. Please also see Response 12 below. Response 12. In response to the Referee's comment, we quantified the expression levels of key genes by qPCR in VR (+) cells administered LDN, as performed in the original manuscript. As shown in Fig. 3J in the revised manuscript, first, we found that the levels of VR expression in females, but not males, administered LDN appeared to decrease compared to those in the controls.
Second, consistent with the IF data that we showed in the original/revised manuscript (Fig. 3H, I ), the expression levels of genes such as Id1, Ddx4, Dazl, Sycp3 and Prdm9, but, interestingly, not Stra8, appeared to be down-regulated in VR (+) cells in female embryos with LDN administration compared to those in the control mice (Fig. 3K) . In contrast, the expression levels of genes such as Ddx4, Dazl, Nanos2 and Dnmt3l did not show substantial change in VR-positive cells in male embryos with LDN administration (Fig. 3K in the revised manuscript) . It is also of note that we did not detect expression of Id1 and Id2 in male VR (+) cells (Fig. 3K in the revised manuscript) . These findings strongly suggest that the BMP signaling would be dispensable/not active in the male germ cell specification pathway. We provided these data and relevant statements in the revised manuscript (Fig. 3J, K, p 8 , "BMP and RA commit PGCs to the female fate" section, the second paragraph, in the revised manuscript). Response 15. According to the Referee's comment, we provided a revised scheme that illustrates the findings of our study more clearly (Fig. 7A in the revised manuscript) . Thank you for submitting your revised manuscript for consideration by The EMBO Journal, and your patience with our response. Your revised study was sent back to referees #2 and #3 for reevaluation. Please note that while referee #3 was not able to look back into the manuscript this time, we have editorially assessed his/her criticism and found that all concerns were adequately addressed. Please find the comments of referee #2 enclosed below.
REFFERENCES
As you will see, referee #2 finds that his/her concerns have been sufficiently addressed and is in broadly favour of publication, pending minor revisions.
Thus, we are pleased to inform you that your manuscript has been accepted in principle for publication in The EMBO Journal, pending some minor issues on material & methods and formal formatting as outlined below, which need to be adjusted at re-submission.
REFEREE REPORT
We again carefully looked at the paper and think that the paper is ready for acceptance. One minor point is that the "materials and methods" information related to figure 6E appears to us to be missing. Do the data meet the assumptions of the tests (e.g., normal distribution)? Describe any methods used to assess it.
Is there an estimate of variation within each group of data?
Is the variance similar between the groups that are being statistically compared?
6. To show that antibodies were profiled for use in the system under study (assay and species), provide a citation, catalog number and/or clone number, supplementary information or reference to an antibody validation profile. e.g., Antibodypedia (see link list at top right), 1DegreeBio (see link list at top right).
7. Identify the source of cell lines and report if they were recently authenticated (e.g., by STR profiling) and tested for mycoplasma contamination.
* for all hyperlinks, please see the table at the top right of the document See Figure 6F and its legend.
Before perfoming t--test (non--paired), we examined the normality and equal variance of the samples tested. Normality was confirmed by Kolmogorov--Smirnov test and equality was confirmed by f--test. 
Data
the data were obtained and processed according to the field's best practice and are presented to reflect the results of the experiments in an accurate and unbiased manner. figure panels include only data points, measurements or observations that can be compared to each other in a scientifically meaningful way. graphs include clearly labeled error bars for independent experiments and sample sizes. Unless justified, error bars should not be shown for technical replicates. if n< 5, the individual data points from each experiment should be plotted and any statistical test employed should be justified the exact sample size (n) for each experimental group/condition, given as a number, not a range;
Each figure caption should contain the following information, for each panel where they are relevant:
Captions
The data shown in figures should satisfy the following conditions:
Source Data should be included to report the data underlying graphs. Please follow the guidelines set out in the author ship guidelines on Data Presentation.
Please fill out these boxes  (Do not worry if you cannot see all your text once you press return) a specification of the experimental system investigated (eg cell line, species name). Any descriptions too long for the figure legend should be included in the methods section and/or with the source data.
C--
In the pink boxes below, please ensure that the answers to the following questions are reported in the manuscript itself. Every question should be answered. If the question is not relevant to your research, please write NA (non applicable). We encourage you to include a specific subsection in the methods section for statistics, reagents, animal models and human subjects.
definitions of statistical methods and measures:
a description of the sample collection allowing the reader to understand whether the samples represent technical or biological replicates (including how many animals, litters, cultures, etc.). 
